Literature DB >> 14528066

Cutaneous hand and foot toxicity associated with cancer chemotherapy.

June Childress1, Jake Lokich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14528066     DOI： 10.1097/01.coc.0000026486.56886.18

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN： 0277-3732            Impact factor:   2.339


× No keyword cloud information.
  12 in total

1.  [Palmoplantar erythrodysesthesia after intravenous therapy with docetaxel].

Authors:  S Meller; J Reifenberger; H Stege; T Ruzicka; B Homey
Journal:  Hautarzt       Date:  2005-10       Impact factor: 0.751

2.  Optimisation of steroid prophylaxis schedules in breast cancer patients receiving docetaxel chemotherapy-a survey of health care providers and patients.

Authors:  Carmel Jacobs; Brian Hutton; Sasha Mazzarello; Stephanie Smith; Anil Joy; Eitan Amir; Mohammed F K Ibrahim; Nancy Gregario; Kelly Daigle; Lori Eggert; Mark Clemons
Journal:  Support Care Cancer       Date:  2015-05-03       Impact factor: 3.603

Review 3.  Clinical presentation and management of hand-foot skin reaction associated with sorafenib in combination with cytotoxic chemotherapy: experience in breast cancer.

Authors:  Patricia Gomez; Mario E Lacouture
Journal:  Oncologist       Date:  2011-10-20

4.  Case series of docetaxel-induced dorsal hand-foot syndrome.

Authors:  Jolly Patel; J Tanner Ringley; Donald C Moore
Journal:  Ther Adv Drug Saf       Date:  2018-05-21

Review 5.  Dermatological adverse events with taxane chemotherapy.

Authors:  Vincent Sibaud; Nicole R Lebœuf; Henri Roche; Viswanath R Belum; Laurence Gladieff; Marion Deslandres; Marion Montastruc; Audrey Eche; Emmanuelle Vigarios; Florence Dalenc; Mario E Lacouture
Journal:  Eur J Dermatol       Date:  2016-10-01       Impact factor: 3.328

6.  Pharmacokinetic interaction between taxanes and amiodarone leading to severe toxicity.

Authors:  Felix Hammann; Verena Gotta; Katrin Conen; Michael Medinger; Philipp Cesana; Christoph Rochlitz; Anne B Taegtmeyer
Journal:  Br J Clin Pharmacol       Date:  2016-11-20       Impact factor: 4.335

7.  Docetaxel-induced skin toxicities in breast cancer patients subsequent to paclitaxel shortage: a case series and literature review.

Authors:  Ming J Poi; Michael Berger; Maryam Lustberg; Rachel Layman; Charles L Shapiro; Bhuvaneswari Ramaswamy; Ewa Mrozek; Erin Olson; Robert Wesolowski
Journal:  Support Care Cancer       Date:  2013-05-19       Impact factor: 3.603

8.  Levofolene modulates apoptosis induced by 5-fluorouracil through autophagy inhibition: clinical and occupational implications.

Authors:  Monica Lamberti; Stefania Porto; Silvia Zappavigna; Paola Stiuso; Virginia Tirino; Vincenzo Desiderio; Luigi Mele; Michele Caraglia
Journal:  Int J Oncol       Date:  2015-02-24       Impact factor: 5.650

9.  Management of cytotoxic chemotherapy-induced hand-foot syndrome.

Authors:  Johannes J M Kwakman; Yannick S Elshot; Cornelis J A Punt; Miriam Koopman
Journal:  Oncol Rev       Date:  2020-05-13

10.  Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling.

Authors:  M Martín; J C de la Torre-Montero; S López-Tarruella; K Pinilla; A Casado; S Fernandez; Y Jerez; J Puente; I Palomero; R González Del Val; M Del Monte-Millan; T Massarrah; C Vila; B García-Paredes; J A García-Sáenz; A Lluch
Journal:  Breast Cancer Res Treat       Date:  2018-06-19       Impact factor: 4.872
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.